Schott Pharma AG & CO KGaA
Schott Pharma AG & Co KGaA is a German multinational specialty pharmaceutical packaging enterprise headquartered in Mainz, Germany. The company specializes in the development, manufacturing, and distribution of high-quality glass and polymer containment solutions for injectable drugs, including pre-fillable glass syringes, drug cartridges, vials, and ampoules utilized by global pharmaceutical corporations. Principal revenue is derived through wholesale manufacturing sales of advanced containment systems to pharmaceutical manufacturers. Schott Pharma AG & Co KGaA is publicly listed on the Frankfurt Stock Exchange.
7 of the funds FundTelligence covers report a position in Schott Pharma AG & CO KGaA.
- Sector
- Health Care
- Country
- Germany
- Funds holding it
- 7
Funds holding Schott Pharma AG & CO KGaA
- Aktie-Ansvar Europa — Aktie-Ansvar · 3.04 % (full portfolio disclosed, June 2026)
- Allianz Europe Small Cap Equity — Allianz Global Investors · 2.62 % (largest positions only, September 2026)
- Schroder ISF European Smaller Companies — Schroders · 2.49 % (full portfolio disclosed, June 2026)
- T. Rowe Price European Smaller Companies Equity — T. Rowe Price · 1.11 % (full portfolio disclosed, September 2026)
- Schroder ISF European Equity Impact — Schroders · 0.22 % (full portfolio disclosed, December 2025)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)
- DNB Global Enhanced Index — DNB · 0.0 % (full portfolio disclosed, September 2026)